Share
Contact Us
Share
:::Menu
What's New
Online Registration
Patient Guide
Features
Honors
Health Examination
Stories
International Medical Service Center
Division of Heart Failure
Cited (8)
2018/11/16 11:54:20
1937
| Site：Division of Heart Failure Position： E-Mail：cvctc@vghtc.gov.tw |
TEL：(04)2359-2525-3124 FAX：(04)2359-5046 |
Congestive heart failure is a complex syndrome that is the endpoint of variable cardiac conditions, including ischemic, valvular cardiomyopathy, myocarditis, or even congenital heart disease. It is always the challenge for clinical physician to help patients with advanced heart failure, with regarding to readmission rate and long term survival, which is a huge burden to National Healthcare system.
In order to provide specialized and integrated medical care for patients with advanced heart failure, the functional team was organized by Chief Dr. Jin-Long Huang in 2004. Later, in 2014, Division of Heart Failure is established as the formal division to integrate and improve all aspects of heart failure caring, including medication, invasive device implantation, rehabilitation and palliative therapy.
In addition to optimal medication guided by national and global guideline of heart failure, we are also specialized in comprehensive, tailored treatment for patients, including program of “Quality Control Circle “awarded with Gold Medal from Joint Commission of Taiwan; Besides, the special therapies, including EECP (enhanced external counter-pulsation), CRT-P/D (cardiac resynchronization therapy-pacemaker/defibrillator), which also improve patients’ quality of life and even long term survival. For the patients with heart failure in the terminal stage, we collaborate with division of Traditional Chinese Medicine and establish recipient candidate list of heart transplantation.
Known as a tertiary medical center, and specific division of heart failure, we also devote to update researches in substrate analysis of patients with heart failure and ventricular arrhythmia; impaction of myocardial scar on patients’ response to CRT-P/D, by the nuclear medicine with Prof. Chen Ji in the Emory University, USA. Besides, we also introduce update new drugs for heart failure including levosimeden, ivabradine.